Transfusion-Transmitted Cytomegalovirus: The Part-Time Pathogen

References

• Skolnik P R, Kosloff B R, Hirsch M S. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis 1988; 157: 500–14
   Web of Science ®Google Scholar
• Davis M G, Kenney S C, Kamine J, Pagano J S, Huany E S. Immediate-early gene region of human cytomegalovirus transactivates the promoter of human immunodeficiency virus. Proc Natl Acad Sci USA 1987; 84: 8642–6
   PubMed Web of Science ®Google Scholar
• Kreel I, Zarroff L I, Canter J W. A syndrome following total body perfusion. Surg Gynecol Obstet 1960; 111: 317–21
   PubMedGoogle Scholar
• Prince A M, Szmuness W, Millian S J, David D S. A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med 1971; 284: 1125–31
   PubMed Web of Science ®Google Scholar
• Lamberson H V. Cytomegalovirus (CMV). The agent, its pathogenesis and its epidemiology. Infection, Immunity and Blood Transfusion, R Y Dodd, L F Barber. Alan R Liss, New York 1985; 149–73
   Google Scholar
• Adler S P. Neonatal cytomegalovirus infections due to blood. CRC Crit Rev Clin Lab Sci 1985; 23: 1–14
   Google Scholar
• Tegtmeier G E. Cytomegalovirus infection as a complication of blood transfusion. Semin Liver Dis 1986; 6: 82–95
   PubMed Web of Science ®Google Scholar
• Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990; 12(Suppl 7)5701–10
   Google Scholar
• Bowden R, Sayers M. The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion 1990; 30: 762–3
   PubMed Web of Science ®Google Scholar
• Taylor-Wiedeman J, Sissons P, Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 1994; 68: 1597–604
   PubMedGoogle Scholar
• Minton E J, Tysoe C, Sinclair J H, Sissons JG P. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 1994; 68: 4017–21
   PubMedGoogle Scholar
• Gerna G, Zipeto D, Percivalle E, et al. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis 1992; 166: 1236–44
   PubMed Web of Science ®Google Scholar
• Kane R C, Rousseau W E, Noble G R, et al. Cytomegalovirus infection in a volunteer blood donor population. Infect Immun 1975; 17: 719–23
   Web of Science ®Google Scholar
• Perham TG M, Carl E W, Conway P J, Mott M G. Cytomegalovirus infection in blood donors—a prospective study. Br J Haematol 1971; 20: 307–20
   PubMed Web of Science ®Google Scholar
• Mirkovic R, Werch J, South M A, Beyesch-Melnick N. Incidence of cytomegaloviremia in blood bank donors and in infants with congenital cytomegalic inclusion disease. Infect Immun 1971; 3: 45–50
   PubMed Web of Science ®Google Scholar
• Diosi P, Moldovan E, Tomescu N. Latent cytomegalovirus infection in blood donors. Br Med J 1969; 4: 660–2
   PubMed Web of Science ®Google Scholar
• Cheung K S, Lang D J. Transmission and activation of cytomegalovirus with blood transfusion: A mouse model. J Infect Dis 1977; 135: 841–5
   PubMed Web of Science ®Google Scholar
• Speir E, Modali R, Huang E S, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391–4
   PubMed Web of Science ®Google Scholar
• Weber B, Hamann A, Ritt B, Rabenau H, Braun W, Doerr H W. Comparison of shell vial culture and serology for the diagnosis of human cytomegalovirus infection in neonates and immunocompromised subjects. Clin Invest 1992; 70: 503–7
   PubMedGoogle Scholar
• Booth J C, Hannington G, Bakir TM F, et al. Comparison of enzyme linked immunoabsorbent assay, radio-immunoassay, complement function, anticomplement immunofluorescence and passive hemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol 1982; 35: 1345–8
   PubMed Web of Science ®Google Scholar
• Fiesthumel S, Lentz E, Arnold C, McMahon C, Dock N, Lamberson H. Cytomegalovirus (CMV) infection in blood donors: Correlation of serologic markers with viral shedding. Transfusion 1986; 26: 54, Abstract.
   Web of Science ®Google Scholar
• Tegtmeier G E. Posttransfusion cytomegalovirus infections. Arch Pathol Lab Med 1989; 113: 236–45
   PubMed Web of Science ®Google Scholar
• Miller M J, Bovey S, Pado K, Bruckner D A, Wagar E A. Application of PCR to multiple specimen types for diagnosis of cytomegalovirus infection: Comparison with cell culture and shell vial assay. J Clin Microbiol 1994; 32: 5–10
   PubMed Web of Science ®Google Scholar
• Drouet E, Michelson S, Denoyel G, Colimon R. Polymerase chain reaction detection of human cytomegalovirus in over 2000 blood specimens correlated with virus isolation and related to urinary virus excretion. J Virol Methods 1993; 45: 259–76
   PubMed Web of Science ®Google Scholar
• Schmidt C A, Oettle H, Neuhaus P, et al. Demonstration of cytomegalovirus by polymerase chain reaction after liver transplantation. Transplantation 1993; 56: 872–4
   PubMed Web of Science ®Google Scholar
• Drouet E, Boibieux A, Michelson S, et al. Polymerase chain reaction detection of cytomegalovirus DNA in peripheral blood leukocytes as a predictor of cytomegalovirus disease in HIV-infected patients. AIDS 1993; 7: 665–8
   PubMed Web of Science ®Google Scholar
• Ratnamohan V M, Mathys J M, McKenzie A, Cunningham A L. HCMV-DNA is detected more frequently than infectious virus in blood leukocytes of immunocompromised patients: A direct comparison of culture-immunofluorescence and PCR for detection of HCMV in clinical specimens. J Med Virol 1992; 38: 252–9
   PubMed Web of Science ®Google Scholar
• Gozlan J, Salord J M, Chovaid C, et al. Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: Diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J Clin Microbiol 1993; 31: 1943–5
   PubMed Web of Science ®Google Scholar
• McCracken G H, Shinefield H R, Cobb K, Rausen A R, Dische M R, Eichenwald H F. Congenital cytomegalic inclusion disease. Am J Dis Child 1969; 117: 522–39
   PubMedGoogle Scholar
• McEnery G, Stern H. Cytomegalovirus infection in early infancy: Five atypical cases. Arch Dis Child 1970; 45: 669–73
   PubMed Web of Science ®Google Scholar
• King-Lewis P A, Gardner S D. Congenital cytomegalic inclusion disease following intrauterine transfusion. Br Med J 1969; 2: 603–5
   PubMed Web of Science ®Google Scholar
• Evans DG R, Lyon A J. Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion. Eur J Pediatr 1991; 150: 780–1
   PubMed Web of Science ®Google Scholar
• Kumar A, Nankervis G A, Cooper R A, Gold E, Kumar M L. Acquisition of cytomegalovirus infection in infants following exchange transfusion: A prospective study. Transfusion 1980; 20: 327–31
   PubMed Web of Science ®Google Scholar
• Pass M A, Johnson J D, Schulman I A, et al. Evaluation of a walking-donor blood transfusion program with intensive care nursery. J Pediatr 1976; 89: 646–51
   PubMed Web of Science ®Google Scholar
• Tobin JO H, MacDonald H, Brayshay M. Cytomegalovirus infection and exchange transfusion. Br Med J 1975; 4: 404, Letter.
   Google Scholar
• Yeager A S. Transfusion-acquired cytomegalovirus infection in newborn infants. Am J Dis Child 1974; 128: 478–83
   PubMedGoogle Scholar
• Tegtmeier G E. Cytomegalovirus and blood transfusion. Infection, Immunity and Blood Transfusion, R Y Dodd, L F Barker. Alan R Liss, New York 1985; 175–99
   Google Scholar
• Lamberson H V, McMillan J A, Weiner L B, et al. Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening donors for IgM to CMV. J Infec Dis 1988; 157: 820–3
   PubMed Web of Science ®Google Scholar
• Preiksaitis J K, Brown L, McKenzie M. Transfusion-acquired cytomegalovirus infection in neonates. Transfusion 1988; 28: 205–9
   PubMed Web of Science ®Google Scholar
• Galea G, Urbanlak S J. Cytomegalovirus studies on blood donors in north-east Scotland and a review of UK data. Vox Sang 1993; 64: 24–30
   PubMed Web of Science ®Google Scholar
• Meyers J D, Flournoy N, Thomas E D. Risk factors for cytomegalovirus infection after human marrow transplant. J Infect Dis 1986; 153: 478–88
   PubMed Web of Science ®Google Scholar
• Pecago R, Hill R, Applebaum F R, et al. Interstitial pneumonitis following autologous bone marrow transplant. Transplantation 1986; 42: 515–7
   PubMed Web of Science ®Google Scholar
• Wingard J R, Chen D Y, Burn W H, et al. Cytomegalovirus infection after autologous bone marrow transplant with comparison to infection after allogeneic bone marrow transplantation. Blood 1988; 71: 1432–7
   PubMed Web of Science ®Google Scholar
• Kelsey S M, Newland A C. Cytomegalovirus seroconversion in patients receiving intensive induction therapy prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 543–6
   PubMed Web of Science ®Google Scholar
• Hersman J, Meyers J D, Thomas E D, et al. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after marrow transplantation. Ann Intern Med 1982; 96: 149–52
   PubMed Web of Science ®Google Scholar
• Bowden R A, Sayers M, Flounoy N, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986; 314: 1006–10
   PubMed Web of Science ®Google Scholar
• MacKinnon S, Burnett A K, Crawford R J, Cameron S, Leask B G, Sommerville R G. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. J Clin Pathol 1988; 41: 948–50
   PubMed Web of Science ®Google Scholar
• Rubie H, Altal M, Compardou A M, et al. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products. Bone Marrow Transplant 1993; 11: 209–14
   PubMed Web of Science ®Google Scholar
• Miller W J, McCollough J, Balfour H H, Jr, et al. Prevention of cytomegalovirus infection following bone marrow transplantation: A randomized trial of blood product screening. Bone Marrow Transplant 1991; 7: 227–34
   PubMed Web of Science ®Google Scholar
• Reusser P, Fisher L D, Bucker C D, Thomas E D, Meyers J D. Cytomegalovirus infection after autologous bone marrow transplantation: Occurrence of cytomegalovirus disease and effect on engraftment. Blood 1990; 75: 1888–94
   PubMed Web of Science ®Google Scholar
• Cray C, Levy R B. CD8+ and CDY+ T cells contribute to the exacerbation of class I MHC disparate graft-vs-host reaction by concurrent murine cytomegalovirus infection. Clin Immunol Immunopathol 1993; 67: 84–90
   PubMedGoogle Scholar
• Boland G J, Vlieger A M, Ververs C, DeGast G C. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation. Clin Exp Immunol 1993; 88: 506–11
   Web of Science ®Google Scholar
• Peterson P K, Anderson R C. Infection in renal transplant recipients. Ann J Med 1986; 81(Suppl a)1–10
   Google Scholar
• Smiley M L, Wlodaver C G, Grossman R A, et al. The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 1985; 40: 157–61
   PubMed Web of Science ®Google Scholar
• Peterson P K, Balfour H H, Jr, Marker S C, Fryd D S, Howard R J, Simmons R L. Cytmegalovirus disease in renal allograft recipients: A prospective study of the clinical features risk factors and impact on renal transplantation. Medicine (Baltimore) 1980; 59: 283–300
   PubMed Web of Science ®Google Scholar
• Bia M J, Andiman W, Gaudio K, et al. Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection post transplantation. Transplantation 1985; 40: 610–4
   PubMed Web of Science ®Google Scholar
• Peterson P K, Balfour H H, Jr, Fryd D S, Ferguson R, Kronenberg R, Simmons R L. Risk factors in the development of cytomegalovirus related pneumonia in renal transplant recipients. J Infect Dis 1983; 148: 1121, Letter.
   PubMed Web of Science ®Google Scholar
• Weir M R, Henry M L, Blackman M, et al. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor specific transfusion and living-related donor transplantation. Transplantation 1988; 45: 111–6
   PubMed Web of Science ®Google Scholar
• Pass R F, Whitley R J, Diethelm A G, et al. Cytomegalovirus infection in patients with renal transplants: Potentiation by antithymocyte globulin and an incompatible graft. J Infect Dis 1980; 142: 9–17
   PubMed Web of Science ®Google Scholar
• Fujinami R S, Nelson J A, Walker L, Oldstone M S. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: A means for graft rejection and immunosuppression. J Virol 1988; 62: 100–5
   PubMed Web of Science ®Google Scholar
• Chou S, Kim D Y, Norman D J. Transmission of cytomegalovirus by pretransplant leukocyte transfusion in renal transplant candidates. J Infect Dis 1987; 155: 565–7
   PubMed Web of Science ®Google Scholar
• Grundy J E, Super M, Sweny P, et al. Symptomatic cytomegalovirus infection in seropositive kidney recipients: Reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988; 2: 132–5
   PubMed Web of Science ®Google Scholar
• Grattan M T, Moreno-Cabral C E, Starnes V A, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561–6
   PubMed Web of Science ®Google Scholar
• Wreghitt T G, Hakin M, Gray J, Kucia S, Wallwork J, English TA H. Cytomegalovirus infections in heart and lung transplant recipients. J Clin Pathol 1988; 41: 660–7
   PubMed Web of Science ®Google Scholar
• Duncan A J, Dummer J S, Paradis I L, et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991; 10: 638–44
   PubMed Web of Science ®Google Scholar
• Smyth R L, Scott J P, Borysiewicz L K, et al. Cytomegalovirus infection in heart-lung transplant recipients: Risk factors, clinical associations, and response to treatment. J Infect Dis 1991; 164: 1045–50
   PubMed Web of Science ®Google Scholar
• Condie R M, O'Reilly R J. Prevention of cytomegalovirus infection by prophylaxis with an intravenous hyperimmune, native unmodified cytomegalovirus globulin. Am J Med 1984; 76((Suppl))134–41
   PubMed Web of Science ®Google Scholar
• Paya C V, Hermans P E, Wiesner R H, et al. Cytomegalovirus hepatitis in liver transplantation: Prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989; 160: 752–8
   PubMed Web of Science ®Google Scholar
• Mañez R, Kusue S, Martin M, et al. The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 1993; 33: 594–7
   PubMed Web of Science ®Google Scholar
• Rakela J, Wiesner R H, Taswell H F, et al. Incidence of cytomegalovirus infection and its relationship to donor-recipient. Transplant Proc 1987; 19: 2399–402
   PubMed Web of Science ®Google Scholar
• Breinig M K, Zitelli B, Starzl T E, Ho M. Epstein-Barr virus cytomegalovirus and other viral infections in children after liver transplantation. J Infect Dis 1987; 156: 273–9
   PubMed Web of Science ®Google Scholar
• Drew W L. Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988; 158: 449–56
   PubMed Web of Science ®Google Scholar
• Busch M P, Lee T H, Heitman J. Allogeneic leukoyctes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: Implications for transfusion support of infected patients. Blood 1992; 80: 2128–35
   PubMed Web of Science ®Google Scholar
• Vamvakas E, Kaplan H S. Early transfusion and length of survival in acquired immune deficiency syndrome: Experience with a population receiving medical care at a public hospital. Transfusion 1993; 33: 111–8
   PubMed Web of Science ®Google Scholar
• Sloand E, Kumar P, Klein H G, Merritt S, Sacher R. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: Relationship to opportunistic infection. Transfusion 1994; 34: 48–53
   PubMed Web of Science ®Google Scholar
• Cox F, Hughes W T. Cytomegaloviremia in children with acute lymphocytic leukemia. J Pediatr 1975; 87: 190–4
   PubMed Web of Science ®Google Scholar
• Cox F, Hughes W T. The value of isolation procedures for cytomegalovirus infection in children with leukemia. Cancer 1975; 36: 1158–61
   PubMed Web of Science ®Google Scholar
• Stevens D P, Barker L F, Ketcham A S, et al. Asymptomatic cytomegalovirus infection following blood transfusion in tumor surgery. JAMA 1979; 211: 1341–4
   Google Scholar
• Drew N L, Minor R C. Transfusion-related cytomegalovirus infection following noncardiac surgery. JAMA 1982; 247: 2389–91
   PubMed Web of Science ®Google Scholar
• Baumgartner J D, Glauser M P, Burgo-Black A L, Black R D, Pyndia N, Chiolero R. Severe cytomegalovirus infection in multiply transfused, splenectomized, trauma patients. Lancet 1982; 2: 63–6
   PubMed Web of Science ®Google Scholar
• Rader D C, Nucha P, Moore S B, Farnell B B, Edson R S, Smith R F. Cytomegalovirus infection in patients undergoing noncardiac surgical procedures. Surg Gynecol Obstet 1985; 160: 13–6
   PubMedGoogle Scholar
• Stratta R J, Warden G D, Nimmemann J L, Saffle J R. Immunologic parameters in burned patients: Effect of therapeutic interventions. J Trauma 1986; 26: 7–17
   PubMedGoogle Scholar
• Kealey G P, Bale J F, Strauss R G, Massanari R V. Cytomegalovirus infection in burn patients. J Burn Care Rehabil 1987; 8: 543–5
   PubMedGoogle Scholar
• Wilhelm J A, Maher L, Schopfer K. The risk of transmitting cytomegalovirus to patients receiving blood transfusions. J Infect Dis 1986; 154: 169–71
   PubMed Web of Science ®Google Scholar
• Bale J F, Jr, Kealey G P, Massanari R M, Strauss R G. The epidemiology of cytomegalovirus infection among patients with burns. Infect Control Hosp Epidemiol 1990; 11: 17–22
   PubMed Web of Science ®Google Scholar
• Kagan R J, Naraqui S, Matsuda T, et al. Herpes simplex virus and cytomegalovirus infections in burned patients. J Trauma 1985; 25: 40–5
   PubMedGoogle Scholar
• Gjesdal K, Orstavik I, Fagerhol M, et al. Blood donor selection can prevent cytomegalovirus infection after open heart surgery. Eur Heart J 1987; 8: 370–85
   Web of Science ®Google Scholar
• Curtsinger L J, Cheadle W G, Hershman M J, Cost K, Polk H C, Jr. Association of cytomegalovirus infection with increased morbidity is independent of transfusion. Am J Surg 1989; 158: 606–10
   PubMed Web of Science ®Google Scholar
• Preiksaitis J K, Grumet F C, Smith W K, Merigen T C. Transfusion-acquired cytomegalovirus infection in cardiac surgery patients. J Med Virol 1985; 15: 283–90
   PubMed Web of Science ®Google Scholar
• Beneke J S, Tegtmeier G E, Alter H J, Leutkemeyer R B, Solomon R, Bayer W L. Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection. J Infect Dis 1984; 150: 883–8
   PubMed Web of Science ®Google Scholar
• Germenis A, Politis C. Thalassemic patients are at high risk for transfusion-transmitted cytomegalo-virus infections. Acta Haematol 1989; 82: 57–60
   PubMed Web of Science ®Google Scholar
• DeMontalembert M, Costagliola D G, Lefrere J J, et al. Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. Transfusion 1992; 32: 509–12
   PubMed Web of Science ®Google Scholar
• Demmler G J, Brady M T, Bijou H, et al. Posttransfusion cytomegalovirus infection in neonates: Role of saline-washed red blood cells. J Pediatr 1986; 108: 762–5
   PubMed Web of Science ®Google Scholar
• Luban NL C, Williams A E, MacDonald M G, Mikesell G, Williams K, Sacher R A. Low incidence of acquired cytomegalovirus infections transfused with washed red blood cells. Am J Dis Child 1987; 141: 416–9
   PubMedGoogle Scholar
• Smith K L, Cobain T, Dunstan R A. Removal of cytomegalovirus DNA from donor blood by filtration. Br J Haematol 1993; 83: 640–2
   PubMed Web of Science ®Google Scholar
• deGraan-Hentzen Y C, Gratama J W, Mudde G C, et al. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989; 29: 757–60
   PubMed Web of Science ®Google Scholar
• Eisenfeld L, Silver H, McLaughlin J. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 1992; 32: 205–9
   PubMed Web of Science ®Google Scholar
• Gilbert G L, Hayes K, Hudson I L, et al. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leukocytes. Lancet 1989; 2: 1228–31
   PubMed Web of Science ®Google Scholar
• Bowden R A, Sayer M H, Cays M, Slichter S J. The role of blood product filtration in the prevention of transfusion associated cytomegalovirus (CMV) infection after marrow transplant. Transfusion 1989; 20(suppl)575, Abstract.
   Google Scholar
• Bowden R A, Cays M, Schoch G, et al. Comparison of filtered blood to seronegative blood products for prevention of cytomegalovirus infection after marrow transplant. Blood 1993; 82(suppl 1)204A, Abstract.
   Google Scholar